Skip to main content

International Psoriasis Council

Advancing Knowledge. Improving Care.

Welcoming Our Newest IPC Councilors: Leaders in Psoriasis Treatment and Research

Join us in welcoming IPC’s newest Councilors: Christopher Bunick, Jeffrey Cohen, Giovanni Damiani, Victoria Guillano, Renata Magalhães, Eingun James Song, and Yi Xiao. Recently appointed and selected by the IPC Board of Directors, these experts are dedicated to enhancing global research on psoriasis and improving patient care.

As IPC Councilors, they will leverage their expertise to advance IPC initiatives in research, treatment, and education on a global scale, aligning with our commitment to improving the health and well-being of people with psoriasis worldwide. We invite you to learn more about these psoriasis experts through their biographies and discover how they contribute to our mission of enhancing patient outcomes and empowering health care professionals.

Let’s warmly welcome Christopher Bunick, Jeffrey Cohen, Giovanni Damiani, Victoria Guillano, Renata Magalhães, Eingun James Song, and Yi Xiao as they join the IPC Councilor community. Their addition underscores IPC’s commitment to driving positive change and improving global psoriasis care.

Christopher Bunick, MD, PhD

Yale University

New Haven, Connecticut, United States

IPC Councilor

Bio

Jeffrey Cohen, MD, MPH

Yale School of Medicine

New Haven, Connecticut, United States

IPC Councilor

Bio

Giovanni Damiani, MD, PhD

University of Milan

Milan, Italy

IPC Councilor

Bio

Victoria Patiño-Guillano, MD, FPDS, FDSP-PDS, MBA-H

University of Southeastern Philippines; DermPath Dermatology

Tagum, Philippines

IPC Councilor

Bio

Renata Ferreira Magalhães, MD, PhD

Unicamp Clinical Hospital

Campinas, Brazil

IPC Councilor

Bio

Eingun James Song, MD, FAAD

Frontier Dermatology

Mill Creek, Washington, United States

IPC Councilor

Bio

Yi Xiao, MD, PhD, MPH

Department of Dermatology, Xiangya Hospital, Central South University

Changsha, China

IPC Councilor

Bio

Comments are closed.

Categories

Recent Posts

Skin-Derived Myeloid Precursors and Joint-Resident Fibroblasts Spread Psoriatic Disease from Skin to Joints

Fellow Perspectives | Psoriasis Care in Ethiopia: Challenges and Opportunities for Progress

What Matters Most to People with Psoriasis? IPC Members Help Shape a Global Answer

Also Read

Subscribe to the IPC Newsletter

Stay up-to-date on the latest research, news, and upcoming events right in your inbox.

What's New

Videos Now Available from the IPC Symposium at SID Chicago

Did you miss the IPC symposium at the 83rd Society for Investigative Dermatology (SID) Annual Meeting? Select session videos are now available. The Arc of Disease Control in Psoriasis: Early Interception – Deep Pathway Blockade – Treatment Failure covered early intervention strategies, treatment selection, immune pathway targeting, PsA prevention, clinical escape, and real-world cases that inform long-term psoriasis care.

WATCH NOW

Wednesday, June 17, 2026

Take Ten: Mio Nakamura – Psoriasis and Mental Health

Depression affects approximately 20% of patients with psoriasis, five times the rate seen in the general population. IPC Jr. Councilor Mio Nakamura, MD, MS, FAAD, walks through the bidirectional relationship between psoriasis and depression, the shared inflammatory pathways driving both conditions, and practical guidance on screening and incorporating multidisciplinary mental health support into psoriasis management.

WATCH NOW

Thursday, June 11, 2026